Articles

Pfizer’s gene-therapy trial failure boosts Sarepta’s stock

Shares of Sarepta Therapeutics climbed early Thursday after a potential competitor to its gene therapy stumbled in a late-stage trial.

Students at nation’s largest Christian college allege they were duped into enrolling through racketeering scheme

They signed up to earn their graduate degrees with promises they could complete school quickly and affordably. But they wound up mired in extra courses and on the hook for thousands of dollars more than they were told.

Wholesale prices decline and add to evidence of easing U.S. inflation

U.S. wholesale prices fell in May for the second time in three months, potentially another sign that an upturn in inflation earlier this year is fading.

Jobless claims jump to highest level in ten months

Claims up 13,000 to 242,000 versus 225,000 forecast

GameStop shares rally ahead of annual shareholder meeting

GameStop Corp. shares rallied 3.9% in premarket trades Thursday ahead of the videogame retailer’s annual shareholder meeting, which is scheduled for 11 a.m. Eastern Time.

Scientists can now tell if you’ll get Alzheimer’s years in advance — with more than 80% accuracy

A breakthrough will help treatment and drug trials, scientists say.

Moderna says new-generation COVID vaccine more effective than Spikevax for adults 18 and over

Adults aged 18 and older enjoyed higher efficacy in a late-stage trial of Moderna’s next-gen vaccine than the original one.

Retirement is about much more than having enough money

Some financial advisers are trying to help clients with the nonfinancial aspects of retirement

Why Broadcom’s stock could book its biggest gain in four years

The stock is up 14% in premarket action, putting the company on pace to add $100 billion in market cap if that rally holds through Thursday’s close.

3M to transfer pension-payment obligations for 23,000 U.S. retirees

3M said Thursday it will transfer about $2.5 billion of its pension-payment obligations to Met Tower Life.

A higher return than Nvidia’s by 2030? Here’s the stock that will do it, says this analyst

Lead tech analyst at the I/O Fund, Beth Kindig, who has made some prescient calls, says Nvidia can be beat in the long run.

G7 leaders reach agreement to give $50 billion loan to Ukraine: report

The $50 billion loan is set to be backed by €2.5- 3.5 billion annual profits made on €260 billion worth of frozen Russian assets
1 1,325 1,326 1,327 1,328 1,329 2,573